Medical Director, Medical Affairs, Oncology & Rare Disease
Simran Padam, MD, APMMC, serves as the CAR T Medical Director, bringing more than 14 years of experience in global Phase I-III clinical research to Worldwide. With expertise in medical affairs, product development, and strategic planning, she provides comprehensive medical oversight and collaborative leadership across various clinical research initiatives.
Submit an RFP. Ask a Question
Dr. Padam plays a critical role in the design and execution of clinical development programs and works closely with cross-functional teams to ensure the successful delivery of clinical trials. Her role at Worldwide includes providing therapeutic and protocol-specific training to project teams, supporting business development, and ensuring compliance with regulatory requirements. Dr. Padam’s medical input is essential in the preparation of study protocols, final study reports, and other clinical documentation.
She is an active member of several professional societies, including the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), and the American Society of Hematology (ASH). In addition, Dr. Padam has authored 15 peer-reviewed publications and frequently presents at industry conferences, contributing her knowledge and expertise to the global clinical research community.
Dr. Padam received her MD from the Medical University of Lublin, with Certificates of Achievement in Immuno-Oncology and Cancer Genomics and Precision Oncology from Harvard Medical School.